8-47737848-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005195.4(CEBPD):āc.273G>Cā(p.Lys91Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000337 in 1,485,212 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005195.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEBPD | NM_005195.4 | c.273G>C | p.Lys91Asn | missense_variant | 1/1 | ENST00000408965.4 | NP_005186.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEBPD | ENST00000408965.4 | c.273G>C | p.Lys91Asn | missense_variant | 1/1 | NM_005195.4 | ENSP00000386165 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000213 AC: 32AN: 150500Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000173 AC: 27AN: 155646Hom.: 0 AF XY: 0.000158 AC XY: 14AN XY: 88754
GnomAD4 exome AF: 0.000351 AC: 469AN: 1334712Hom.: 1 Cov.: 31 AF XY: 0.000365 AC XY: 242AN XY: 663410
GnomAD4 genome AF: 0.000213 AC: 32AN: 150500Hom.: 0 Cov.: 32 AF XY: 0.0000954 AC XY: 7AN XY: 73408
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.273G>C (p.K91N) alteration is located in exon 1 (coding exon 1) of the CEBPD gene. This alteration results from a G to C substitution at nucleotide position 273, causing the lysine (K) at amino acid position 91 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at